Clearmind Medicine Inc
CMND
Clearmind Medicine Inc AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue TTM with -4.5M cash burn - 9 months runway at current rate (3.5M cash / 4.5M annual burn)[Free Cash Flow TTM]
- Market cap 611K vs 3.5M cash = trading at 0.17x cash; negative EV (-2.9M) signals distress pricing[Enterprise Value]
- R&D spend 2.1M TTM is 37% of total opex - pre-revenue biotech in clinical development phase[Research and Development TTM]
Watch Triggers
- Cash and Equivalents: Falls below 2M or burn rate accelerates — Would signal <6 month runway, forcing emergency financing at punitive terms
- Issuance of Capital Stock: Any equity raise announcement — Dilution timing/terms will determine if equity holders retain meaningful stake
- Research and Development TTM: Material increase or decrease from 2.1M level — Signals either pipeline advancement (bullish) or wind-down (bearish)
Bull Case
Trading below cash value (0.63x book, negative EV) - if pipeline advances, asymmetric upside from depressed base
Clean balance sheet (0.03 D/E, zero long-term debt) preserves optionality for strategic deals or partnerships
Bear Case
Sub-12-month cash runway with zero revenue = imminent dilution or failure; 197K tax paid suggests no NOL shield
ROE -179%, ROIC -175% TTM - destroying capital at accelerating rate with no path to profitability visible
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage CMND's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Binary outcome: either successful capital raise or operational shutdown within 12 months
- Cash runway under 12 months at current burn
- No revenue generation capability
- Zero debt capacity with 1.1M equity base
Valuation Context
Caveats
Public Strategies Rankings
See how Clearmind Medicine Inc ranks across different investment strategies.
Leverage CMND's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
CMND Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$305,019 | — | ||
$-1.84M | — | ||
0.00 | — | ||
$0 | — | ||
$-43.57 | — | ||
0% | 0.0% | — | |
0% | 0.0% | — | |
$-4.73M | — | ||
-1.8 | +77.5% | — | |
Beta 5Y (Monthly) | unknown | — |
CMND Dividend History
CMND Stock Splits
CMND SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
01/20/26 | 10/31/25 | Unknown | |
09/11/25 | 07/31/25 | 6-K | |
06/12/25 | 04/30/25 | 6-K | |
03/13/25 | 01/31/25 | 6-K | |
01/22/25 | 10/31/24 | 20-F | |
09/16/24 | 07/31/24 | 6-K | |
06/13/24 | 04/30/24 | 6-K | |
03/19/24 | 01/31/24 | 6-K | |
01/29/24 | 10/31/23 | 20-F | |
09/13/23 | 07/31/23 | 6-K | |
06/14/23 | 04/30/23 | 6-K | |
03/17/23 | 01/31/23 | 6-K | |
02/06/23 | 10/31/22 | 20-F | |
09/29/22 | 07/31/22 | Quarterly | -- |
06/29/22 | 04/30/22 | Quarterly | -- |
03/25/22 | 01/31/22 | Quarterly | -- |
02/28/22 | 10/31/21 | Annual | -- |
03/18/24 | 10/31/21 | 20-F/A | |
09/29/21 | 07/31/21 | Quarterly | -- |
06/28/21 | 04/30/21 | Quarterly | -- |
03/31/21 | 01/31/21 | Quarterly | -- |
03/01/21 | 10/31/20 | Annual | -- |
09/23/20 | 07/31/20 | Quarterly | -- |
06/25/20 | 04/30/20 | Quarterly | -- |
03/09/20 | 01/31/20 | Quarterly | -- |
02/28/20 | 10/31/19 | Annual | -- |
09/30/19 | 07/31/19 | Quarterly | -- |
07/02/19 | 04/30/19 | Quarterly | -- |
03/15/19 | 01/31/19 | Quarterly | -- |
02/25/19 | 10/31/18 | Annual | -- |
09/24/18 | 07/31/18 | Quarterly | -- |
06/29/18 | 04/30/18 | Quarterly | -- |
03/15/19 | 01/31/18 | Quarterly | -- |
02/25/19 | 10/31/17 | Annual | -- |